🇺🇸 FDA
Patent

US 11834451

Compositions and methods for inhibiting virus protein 2C activity and for preventing and treating non-polio enterovirus infection

granted A61PA61P31/12

Quick answer

US patent 11834451 (Compositions and methods for inhibiting virus protein 2C activity and for preventing and treating non-polio enterovirus infection) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P31/12